Analyst Ratings February 23, 2026

Benchmark Lowers GoDaddy Price Target, Keeps Buy While Pointing to Valuation Reset

Analyst cuts target to $210 as shares trade well below historical multiples; firm says AI and first-party data remain underappreciated

By Caleb Monroe GDDY
Benchmark Lowers GoDaddy Price Target, Keeps Buy While Pointing to Valuation Reset
GDDY

Benchmark reduced its price objective on GoDaddy Inc. to $210 from $240 but retained a Buy rating, citing a valuation reset that has pushed the stock well under historical forward multiples. The firm argues GoDaddy's first-party data advantages and Airo.ai development timeline are not fully reflected in the market price. Other firms highlighted rising engagement with GoDaddy's AI tools and the launch of its Agent Name Service marketplace as signs of product momentum ahead of upcoming quarterly results.

Key Points

  • Benchmark lowered its GoDaddy price target to $210 from $240 but reaffirmed a Buy rating, citing an apparent valuation reset.
  • Shares trade at an 8.7x forward EV/adjusted EBITDA multiple - about 36% below the one-year average of 13.6x - and near a 52-week low; analysis flagged a Fair Value of $130.57 and strong free cash flow generation.
  • GoDaddy's AI initiatives - including Airo.ai and the Agent Name Service marketplace and an integration with Salesforce MuleSoft Agent Fabric - are central to analyst views on future growth and infrastructure positioning.

Benchmark on Monday lowered its price target for GoDaddy Inc. to $210 from $240 while keeping a Buy rating, according to a note released by the firm. The brokerage flagged a meaningful valuation reset in the shares even as it emphasized confidence in GoDaddy's competitive positioning and AI-related economics.

Benchmark pointed to a disconnect between current market pricing and GoDaddy's recent operating performance. The shares are trading at an 8.7x forward EV/adjusted EBITDA multiple, the firm said, a roughly 36% discount to the one-year average forward multiple of 13.6x. Benchmark also highlighted a robust projected cash return profile, noting a 2026 free cash flow yield of 14.4% versus a one-year average of 9.2%.

At the time of the note, the stock was changing hands at $87.40, near its 52-week low of $87.13. A valuation analysis available through InvestingPro indicated a Fair Value estimate of $130.57 and suggested the shares are undervalued. That analysis and related commentary also pointed to a strong implied free cash flow yield, supported by GoDaddy's generation of $1.54 billion in levered free cash flow over the last twelve months. The note referenced the availability of 12 additional ProTips for investors seeking deeper context from that service.

Benchmark argued the current market reset appears to underappreciate two specific drivers. First, the firm cited GoDaddy's differentiation tied to its first-party data. Second, Benchmark said the market is not fully incorporating the timeline for development and commercialization of Airo.ai agents. Management has emphasized opportunities around the Agent Name Service - or ANS - which company leaders view as a potential industry standard for agentic communications and a step toward positioning GoDaddy as an infrastructure provider.

In a demonstration of early enterprise interest, GoDaddy integrated ANS with Salesforce MuleSoft Agent Fabric on February 19. Benchmark noted that ANS is embedded into MuleSoft's enterprise discovery and governance workflow, which the analyst framed as evidence of early demand for governance capabilities in agent deployments.

Investors are due to receive GoDaddy's fourth-quarter results after the market close on Tuesday, February 24. Benchmark's revenue and adjusted EBITDA estimates for the fourth quarter and the first quarter are in line with consensus, the firm said.

Other broker commentary cited in the note and in recent coverage points to growing engagement with GoDaddy's Airo AI tool. Raymond James highlighted an increase in Airo utilization, reporting that agencies have praised the tool's AI output quality and the reliability of its releases. GoDaddy has also launched an Agent Name Service Marketplace, which includes AI agents such as Brand Advisor and Social Media Post Generator and is intended to bolster trust and security in its AI ecosystem.

Analyst positions varied but largely reflected cautious optimism about GoDaddy's AI initiatives. Benchmark maintained its Buy rating, citing conviction in the company's competitive stance and the economics around its AI efforts. Evercore ISI reiterated an In Line rating and pointed to demonstrated Airo use cases, including a custom-built website for microbusinesses. Oppenheimer kept a Perform rating, expressing a constructive view of GoDaddy's strategy to deepen customer engagement through AI offerings.

Taken together, the analyst commentary and product developments underscore management's continued emphasis on leveraging AI tools and platform capabilities to expand the company's product portfolio and market positioning, even as market multiples have reset materially lower.

Risks

  • Valuation uncertainty - the market has repriced GoDaddy to materially lower forward multiples, and that reset could persist despite analyst views - impacting investors in technology and digital services sectors.
  • Earnings and guidance risk - upcoming fourth-quarter results (to be reported after market close on February 24) could prompt revisions to revenue and adjusted EBITDA expectations used by analysts and investors.
  • Execution and adoption risk for AI products - the commercial timelines and customer uptake for Airo.ai agents and the Agent Name Service will determine the extent to which AI initiatives translate into durable revenue growth, affecting enterprise software and AI infrastructure markets.

More from Analyst Ratings

Jefferies Increases Chemours Price Target to $17 Citing Opteon Support; Firm Keeps Hold Rating Feb 23, 2026 Jefferies Lifts Lithium Americas Price Target to $8, Cites Production Ramp and Offtake Visibility Feb 23, 2026 Brookline Capital Lifts C4 Therapeutics Price Target to $30 as Cemsidomide Trials Advance Feb 23, 2026 Jefferies Lifts Fisher & Paykel Healthcare Target After Company Tightens Fiscal 2026 Guidance Feb 23, 2026 William Blair Sticks With Outperform on JFrog as Analysts Weigh Security Positioning Feb 23, 2026